
Share
Dario Amodei predicts steady AI advancement but notes unexpected speed in coding tech; he also outlines Anthropic's cautious approach to innovation and its impact on industry policy.
In a recent podcast with Dwarkesh Patel, Dario Amodei, the CEO of Anthropic, discussed his predictions for AI progress, the company’s strategic decisions, and broader policy considerations. Here are the key takeaways:

Dario Amodei's insights provide a nuanced view of the current state and future trajectory of AI. While rapid progress is expected, especially in coding capabilities, Anthropic’s cautious approach underscores the challenges and risks involved. The discussion also highlights the need for balanced policy and regulation to ensure safe and ethical AI development.
Tags
Original Sources
About the author
Kai built ML infrastructure at a Bay Area startup before developing an obsession with transformer architectures and inference optimisation that eventually pulled him out of product work entirely. A stint at a compute research lab sharpened his instinct for what actually matters in a model release versus what is marketing. He writes from the inside — from the perspective of someone who has debugged the systems he is describing at three in the morning. He is allergic to hype and instinctively drawn to the unglamorous plumbing questions that everyone else skips over.
More from The Engineer →This Week's Edition
17 February 2026
29 articles
Related Articles

Wharton's Fourth Annual AI Survey: Most Companies See Returns, Few See Big Ones
Models & Research · 6 min

Tensormesh Launches Enterprise KV Cache Platform to Cut Redundant LLM Compute
Models & Research · 6 min

Iambic Therapeutics Raises $150 Million in IPO to Fund AI-Designed Cancer Drugs
Finance & Markets · 5 min
Related Articles

Wharton's Fourth Annual AI Survey: Most Companies See Returns, Few See Big Ones
Models & Research · 6 min

Tensormesh Launches Enterprise KV Cache Platform to Cut Redundant LLM Compute
Models & Research · 6 min

Iambic Therapeutics Raises $150 Million in IPO to Fund AI-Designed Cancer Drugs
Finance & Markets · 5 min
More Stories
© 2026 Cedar & Bloom. All rights reserved.